Biohaven Ltd.

NYSE:BHVN

Biotechnology

Healthcare
$13.65 -1.62%

-$0.22 today

Market cap
$2.06B
Beta
3.31
P/E (TTM)
-3.1
EPS (TTM)
-$4.39
52W Low $7.48High $18.57

Volume 3.26M

Average 2.47M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$609.44M

FY 2025 · Annual

Investing Cash Flow

$300.56M

FY 2025 · Annual

Financing Cash Flow

$439.12M

FY 2025 · Annual

-35.2% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(213.8M)(570.28M)(408.17M)(846.42M)(738.82M)
Depreciation & Amortization1.39M1.39M6.91M7.86M9.92M
Deferred Income Tax00000
Stock-Based Compensation65.64M193.56M28.79M71.96M112.36M
Change in Working Capital1.66M(28.6M)24.61M16.81M1.36M
Accounts Receivables00000
Inventory00000
Accounts Payables1.03M5.93M4.87M710K(6.39M)
Other Working Capital639K(34.53M)19.74M16.1M7.74M
Other Non-Cash Items(740K)106.25M16.13M167.34M5.74M
Operating Cash Flow(145.84M)(297.69M)(331.73M)(582.45M)(609.44M)
Capital Expenditures(938K)(41.07M)(3.05M)(4.05M)(715K)
Acquisitions (Net)1.88M00391K0
Purchases of Investments0(263.72M)(194.12M)(745.68M)(266.88M)
Sales of Investments00327M504.36M570M
Other Investing Activities0000(1.85M)
Investing Cash Flow944K(304.79M)129.83M(244.97M)300.56M
Debt Repayment0449.13M00250M
Common Stock Issued0283.8M243.23M675.52M189.31M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities138.45M34.66M(31.32M)2.26M(194K)
Financing Cash Flow138.45M767.6M211.91M677.77M439.12M
Effect of Forex Changes0429K(497K)75K(3K)
Net Change in Cash(6.45M)165.55M9.52M(149.58M)130.24M
Free Cash Flow(146.78M)(338.76M)(334.77M)(586.5M)(610.15M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$738.8M
+ D&A$9.9M
+ Stock-Based Comp$112.4M
+ Deferred Tax$0
+ Working Capital$1.4M
+ Other Non-Cash$5.7M
= Operating Cash Flow-$609.4M
- Capex-$715.0K
= Free Cash Flow-$610.2M

Analysis

FY2025 free cash flow is -$610.2M. FCF conversion is 82.6% of net income. Operating cash flow was -$609.4M, with capex of -$715.0K. The largest bridge item is Stock-Based Comp at $112.4M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportOct 29, 2026
8-KCurrent reportOct 29, 2026
8-KCurrent reportOct 22, 2026
8-KCurrent reportOct 15, 2026
4Statement of changes in beneficial ownershipSep 17, 2026

Does BHVN generate free cash flow?

Biohaven Ltd. (BHVN) generated -$610.15M of free cash flow in fiscal 2025.

How much operating cash flow does BHVN produce?

Operating cash flow was -$609.44M, before capital expenditures of $715,000.00.